Interchange
AUSA Jaime Peña Shares a Tale of Hospital Drug Diversion at Interchange 2014
While participating in an Interchange 2014 panel discussion on criminal prosecutions for drug counterfeiting and drug diversion, Jaime Peña, Assistant U.S. Attorney/Senior Litigation Chief, Criminal Division, Colorado District, U.S. Department of Justice, tells a disturbing story of hospital-based drug diversion. Panel 2 at Interchange 2014, was titled “Patient Safety and Criminal Prosecutions in the U.S.”…
[...]Interchange 2015 Announcement
After five amazing years of the PSM Interchange, we are doing what all good organizations do, and taking a year off to reflect on where we spend our resources and how well we're fulfilling our mission. This could mean new opportunities in global markets and/or a redesign of the event in the U.S. Announcements about our next conference will…
[...]Interchange 2014 Highlights: Pharmaceutical Security Institute CEO Tom Kubic Summarizes This Year’s Drug Counterfeiting, Diversion and Theft Statistics.
At last year’s Interchange, we were pleased to have Tom Kubic, PSM’s treasurer and the president and CEO of the Pharmaceutical Security Institute (PSI), summarize trends in international drug counterfeiting activity and enforcement.
[...]Dr. Marv Shepherd Explains the New USP Good Distribution Practices at Interchange 2014
Dr. Marv Shepherd Explains the New USP Good Distribution Practices at Interchange 2014 At Partnership for Safe Medicines Interchange 2014 in Washington D.C. PSM Board member Dr. Marv Shepherd shared some of the details of the U.S. Pharmacopeia’s soon-to-be-released packaging and distribution updates to its National Formulary.
[...]Put in every story ahead of Interchange
What have we learned from counterfeit Avastin? Hear Dr. Tim Mackey’s new research at the 2014 Interchange. Early bird discounted registration is available until July 30! Click here to register today.
[...]Interchange Keynote Speaker Announced!
The Partnership for Safe Medicines is pleased to announce the keynote speaker for Interchange 2014 on September 18, in Washington DC: Howard Sklamberg, Deputy Commissioner for the FDA’s Global Regulatory Operations and Policy. Deputy Commissioner Sklamberg directs the Office of Regulatory Affairs and the Office of International Programs. He oversees the FDA’s efforts to supervise…
[...]Interchange 2013 Highlights: US Attorney Samuel Louis Describes How a Desire For Diamonds Brought a Master Counterfeiter to Justice
U.S.Attorney Samuel Louis speaking at Interchange 2013 We were fortunate enough to have US Attorney Samuel Louis share details from the counterfeit medication cases he has prosecuted at the Interchange 2013. During the course of his presentation, he described how master drug counterfeiter Kevin Xu was finally brought to justice. Kevin Xu was a businessman…
[...]Interchange 2013 Highlights: Dr. Patrick Lukulay of USP
USP has launched the Center for Pharmaceutical Advancement and Training in Accra, Ghana.Learn more about USP’s efforts to improve the quality of medicines globally at http://www.usp.org/around-world We were most fortunate to have Patrick Lukulay, PhD, Vice President of Global Health Impact Operations for the US Pharmacopeial Convention (USP) as a panelist at this year’s Interchange.…
[...]Partnership for Safe Medicine’s 4th Annual Medicine Safety Conference Success at Newseum in Washington, DC
On October 24th, the Partnership for Safe Medicines gathered stakeholders in the efforts to combat counterfeit medicine in Washington D.C. for a one-day conference at the Newseum’s Knight Conference Center. This was our 4th annual conference, focused on U. S. drug supply chain security and the safety of American patients. Speakers and panelists were drawn…
[...]Will the PSM 2013 Interchange Still Happen During the Government Shutdown?
You can count on it. The criminals who counterfeit drugs and endanger American patients haven’t stopped making and selling fake drugs during the shutdown. There is more need for a counterfeit drug conference now than ever. The 2013 Interchange will include: Patient advocates who represent patients whose lives depend on getting genuine medication Journalists who…
[...]